Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase

Shuang Yang, Xiangdong Zheng, Chao Lu, Guo Min Li, C. David Allis, Haitao Li

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

High-frequency point mutations of genes encoding histones have been identified recently as novel drivers in a number of tumors. Specifically, the H3K36M/I mutations were shown to be oncogenic in chondroblastomas and undifferentiated sarcomas by inhibiting H3K36 methyltransferases, including SETD2. Here we report the crystal structures of the SETD2 catalytic domain bound to H3K36M or H3K36I peptides with SAH (S-adenosylho-mocysteine). In the complex structure, the catalytic domain adopts an open conformation, with the K36M/I peptide snuggly positioned in a newly formed substrate channel. Our structural and biochemical data reveal the molecular basis underying oncohistone recognition by and inhibition of SETD2.

Original languageEnglish (US)
Pages (from-to)1611-1616
Number of pages6
JournalGenes and Development
Volume30
Issue number14
DOIs
StatePublished - Jul 15 2016

Fingerprint

Methyltransferases
Catalytic Domain
Chondroblastoma
Peptides
Point Mutation
Sarcoma
Histones
Mutation
Genes
Neoplasms

Keywords

  • Crystal structure
  • Epigenetic regulation
  • Oncohistone
  • SETD2 methyltransferase

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase. / Yang, Shuang; Zheng, Xiangdong; Lu, Chao; Li, Guo Min; Allis, C. David; Li, Haitao.

In: Genes and Development, Vol. 30, No. 14, 15.07.2016, p. 1611-1616.

Research output: Contribution to journalArticle

Yang, Shuang ; Zheng, Xiangdong ; Lu, Chao ; Li, Guo Min ; Allis, C. David ; Li, Haitao. / Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase. In: Genes and Development. 2016 ; Vol. 30, No. 14. pp. 1611-1616.
@article{4fc6e59821d04e2ca57ccbd4f35cf793,
title = "Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase",
abstract = "High-frequency point mutations of genes encoding histones have been identified recently as novel drivers in a number of tumors. Specifically, the H3K36M/I mutations were shown to be oncogenic in chondroblastomas and undifferentiated sarcomas by inhibiting H3K36 methyltransferases, including SETD2. Here we report the crystal structures of the SETD2 catalytic domain bound to H3K36M or H3K36I peptides with SAH (S-adenosylho-mocysteine). In the complex structure, the catalytic domain adopts an open conformation, with the K36M/I peptide snuggly positioned in a newly formed substrate channel. Our structural and biochemical data reveal the molecular basis underying oncohistone recognition by and inhibition of SETD2.",
keywords = "Crystal structure, Epigenetic regulation, Oncohistone, SETD2 methyltransferase",
author = "Shuang Yang and Xiangdong Zheng and Chao Lu and Li, {Guo Min} and Allis, {C. David} and Haitao Li",
year = "2016",
month = "7",
day = "15",
doi = "10.1101/gad.284323.116",
language = "English (US)",
volume = "30",
pages = "1611--1616",
journal = "Genes and Development",
issn = "0890-9369",
publisher = "Cold Spring Harbor Laboratory Press",
number = "14",

}

TY - JOUR

T1 - Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase

AU - Yang, Shuang

AU - Zheng, Xiangdong

AU - Lu, Chao

AU - Li, Guo Min

AU - Allis, C. David

AU - Li, Haitao

PY - 2016/7/15

Y1 - 2016/7/15

N2 - High-frequency point mutations of genes encoding histones have been identified recently as novel drivers in a number of tumors. Specifically, the H3K36M/I mutations were shown to be oncogenic in chondroblastomas and undifferentiated sarcomas by inhibiting H3K36 methyltransferases, including SETD2. Here we report the crystal structures of the SETD2 catalytic domain bound to H3K36M or H3K36I peptides with SAH (S-adenosylho-mocysteine). In the complex structure, the catalytic domain adopts an open conformation, with the K36M/I peptide snuggly positioned in a newly formed substrate channel. Our structural and biochemical data reveal the molecular basis underying oncohistone recognition by and inhibition of SETD2.

AB - High-frequency point mutations of genes encoding histones have been identified recently as novel drivers in a number of tumors. Specifically, the H3K36M/I mutations were shown to be oncogenic in chondroblastomas and undifferentiated sarcomas by inhibiting H3K36 methyltransferases, including SETD2. Here we report the crystal structures of the SETD2 catalytic domain bound to H3K36M or H3K36I peptides with SAH (S-adenosylho-mocysteine). In the complex structure, the catalytic domain adopts an open conformation, with the K36M/I peptide snuggly positioned in a newly formed substrate channel. Our structural and biochemical data reveal the molecular basis underying oncohistone recognition by and inhibition of SETD2.

KW - Crystal structure

KW - Epigenetic regulation

KW - Oncohistone

KW - SETD2 methyltransferase

UR - http://www.scopus.com/inward/record.url?scp=84980034076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84980034076&partnerID=8YFLogxK

U2 - 10.1101/gad.284323.116

DO - 10.1101/gad.284323.116

M3 - Article

C2 - 27474439

AN - SCOPUS:84980034076

VL - 30

SP - 1611

EP - 1616

JO - Genes and Development

JF - Genes and Development

SN - 0890-9369

IS - 14

ER -